Indirect inhibitory effect of a neurotensin receptor antagonist on human colon cancer (LoVo) growth

K. Iwase, B. M. Evers, Mark Hellmich, H. J. Kim, S. Higashide, D. Gully, Courtney Townsend

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The effect of the nonpeptide neurotensin (NT) receptor antagonist SR48692 on NT-mediated growth of xenografted human colon cancers (LoVo) was determined. Sixty-four athymic nude mice, inoculated with LoVo cells at a single site, were randomized into four groups of 16 mice each to receive either vehicle NT (600 μg/kg), SR48692 (2 mg/kg) or NT+SR48692 administered s.c., t.i.d., for 25 days. Treatment with NT significantly stimulated LoVo tumour growth, weight, DNA and protein content; SR48692 blocked this NT-mediated effect but had no effect when administered as a single agent. In addition, normal jejunum and ileum were removed and assessed. Similar to the effects on LoVo tumours, NT stimulated jejunal and ileal growth; SR48692 blocked this NT-mediated effect. In contrast to our in vivo findings, NT had no effect on LoVo cell growth in vitro. Also, Northern blot analysis demonstrated no expression for the NT receptor in either LoVo tumour cells or xenografted tumours. Our findings suggest that the trophic effect of NT on LoVo may be through an indirect effect; one possibility is that administration of NT may stimulate the release of other trophic factors which then stimulate tumour growth. The nonpeptide NT receptor antagonist SR48692 will be a useful agent to delineate the specific effects of NT on neoplastic as well as normal gastrointestinal tissues.

Original languageEnglish (US)
Pages (from-to)245-251
Number of pages7
JournalSurgical Oncology
Volume5
Issue number5-6
StatePublished - 1996

Fingerprint

Neurotensin Receptors
Neurotensin
Colonic Neoplasms
Growth
Nude Mice
Neoplasms
Jejunum
Tumor Burden
Ileum
Northern Blotting
SR 48692

Keywords

  • Colon cancer
  • LoVo cells
  • Neurotensin
  • Neurotensin antagonist
  • SR48692

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Indirect inhibitory effect of a neurotensin receptor antagonist on human colon cancer (LoVo) growth. / Iwase, K.; Evers, B. M.; Hellmich, Mark; Kim, H. J.; Higashide, S.; Gully, D.; Townsend, Courtney.

In: Surgical Oncology, Vol. 5, No. 5-6, 1996, p. 245-251.

Research output: Contribution to journalArticle

Iwase, K. ; Evers, B. M. ; Hellmich, Mark ; Kim, H. J. ; Higashide, S. ; Gully, D. ; Townsend, Courtney. / Indirect inhibitory effect of a neurotensin receptor antagonist on human colon cancer (LoVo) growth. In: Surgical Oncology. 1996 ; Vol. 5, No. 5-6. pp. 245-251.
@article{e44a26720f24488b95e34bec4a23d160,
title = "Indirect inhibitory effect of a neurotensin receptor antagonist on human colon cancer (LoVo) growth",
abstract = "The effect of the nonpeptide neurotensin (NT) receptor antagonist SR48692 on NT-mediated growth of xenografted human colon cancers (LoVo) was determined. Sixty-four athymic nude mice, inoculated with LoVo cells at a single site, were randomized into four groups of 16 mice each to receive either vehicle NT (600 μg/kg), SR48692 (2 mg/kg) or NT+SR48692 administered s.c., t.i.d., for 25 days. Treatment with NT significantly stimulated LoVo tumour growth, weight, DNA and protein content; SR48692 blocked this NT-mediated effect but had no effect when administered as a single agent. In addition, normal jejunum and ileum were removed and assessed. Similar to the effects on LoVo tumours, NT stimulated jejunal and ileal growth; SR48692 blocked this NT-mediated effect. In contrast to our in vivo findings, NT had no effect on LoVo cell growth in vitro. Also, Northern blot analysis demonstrated no expression for the NT receptor in either LoVo tumour cells or xenografted tumours. Our findings suggest that the trophic effect of NT on LoVo may be through an indirect effect; one possibility is that administration of NT may stimulate the release of other trophic factors which then stimulate tumour growth. The nonpeptide NT receptor antagonist SR48692 will be a useful agent to delineate the specific effects of NT on neoplastic as well as normal gastrointestinal tissues.",
keywords = "Colon cancer, LoVo cells, Neurotensin, Neurotensin antagonist, SR48692",
author = "K. Iwase and Evers, {B. M.} and Mark Hellmich and Kim, {H. J.} and S. Higashide and D. Gully and Courtney Townsend",
year = "1996",
language = "English (US)",
volume = "5",
pages = "245--251",
journal = "Surgical Oncology",
issn = "0960-7404",
publisher = "Elsevier BV",
number = "5-6",

}

TY - JOUR

T1 - Indirect inhibitory effect of a neurotensin receptor antagonist on human colon cancer (LoVo) growth

AU - Iwase, K.

AU - Evers, B. M.

AU - Hellmich, Mark

AU - Kim, H. J.

AU - Higashide, S.

AU - Gully, D.

AU - Townsend, Courtney

PY - 1996

Y1 - 1996

N2 - The effect of the nonpeptide neurotensin (NT) receptor antagonist SR48692 on NT-mediated growth of xenografted human colon cancers (LoVo) was determined. Sixty-four athymic nude mice, inoculated with LoVo cells at a single site, were randomized into four groups of 16 mice each to receive either vehicle NT (600 μg/kg), SR48692 (2 mg/kg) or NT+SR48692 administered s.c., t.i.d., for 25 days. Treatment with NT significantly stimulated LoVo tumour growth, weight, DNA and protein content; SR48692 blocked this NT-mediated effect but had no effect when administered as a single agent. In addition, normal jejunum and ileum were removed and assessed. Similar to the effects on LoVo tumours, NT stimulated jejunal and ileal growth; SR48692 blocked this NT-mediated effect. In contrast to our in vivo findings, NT had no effect on LoVo cell growth in vitro. Also, Northern blot analysis demonstrated no expression for the NT receptor in either LoVo tumour cells or xenografted tumours. Our findings suggest that the trophic effect of NT on LoVo may be through an indirect effect; one possibility is that administration of NT may stimulate the release of other trophic factors which then stimulate tumour growth. The nonpeptide NT receptor antagonist SR48692 will be a useful agent to delineate the specific effects of NT on neoplastic as well as normal gastrointestinal tissues.

AB - The effect of the nonpeptide neurotensin (NT) receptor antagonist SR48692 on NT-mediated growth of xenografted human colon cancers (LoVo) was determined. Sixty-four athymic nude mice, inoculated with LoVo cells at a single site, were randomized into four groups of 16 mice each to receive either vehicle NT (600 μg/kg), SR48692 (2 mg/kg) or NT+SR48692 administered s.c., t.i.d., for 25 days. Treatment with NT significantly stimulated LoVo tumour growth, weight, DNA and protein content; SR48692 blocked this NT-mediated effect but had no effect when administered as a single agent. In addition, normal jejunum and ileum were removed and assessed. Similar to the effects on LoVo tumours, NT stimulated jejunal and ileal growth; SR48692 blocked this NT-mediated effect. In contrast to our in vivo findings, NT had no effect on LoVo cell growth in vitro. Also, Northern blot analysis demonstrated no expression for the NT receptor in either LoVo tumour cells or xenografted tumours. Our findings suggest that the trophic effect of NT on LoVo may be through an indirect effect; one possibility is that administration of NT may stimulate the release of other trophic factors which then stimulate tumour growth. The nonpeptide NT receptor antagonist SR48692 will be a useful agent to delineate the specific effects of NT on neoplastic as well as normal gastrointestinal tissues.

KW - Colon cancer

KW - LoVo cells

KW - Neurotensin

KW - Neurotensin antagonist

KW - SR48692

UR - http://www.scopus.com/inward/record.url?scp=0030433064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030433064&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 245

EP - 251

JO - Surgical Oncology

JF - Surgical Oncology

SN - 0960-7404

IS - 5-6

ER -